This site is intended for healthcare professionals

Neurocrine Biosciences presents new data analyses demonstrating efficacy of once-daily Ongentys in patients with Parkinson's disease at the MDS Virtual Congress 2020.

Read time: 2 mins
Last updated:13th Sep 2020
Published:12th Sep 2020
Condition: Parkinsons
Type: drug
Register free for full access to